In the last trading session, 1.78 million shares of the Aspen Aerogels Inc (NYSE:ASPN) were traded, and its beta was 2.33. Most recently the company’s share price was $7.15, and it changed around $0.08 or 1.13% from the last close, which brings the market valuation of the company to $587.05M. ASPN currently trades at a discount to its 52-week high of $33.15, offering almost -363.64% off that amount. The share price’s 52-week low was $6.60, which indicates that the current value has risen by an impressive 7.69% since then. We note from Aspen Aerogels Inc’s average daily trading volume that its 10-day average is 1.34 million shares, with the 3-month average coming to 1.94 million.
Aspen Aerogels Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.33. If we narrow it down even further, the data shows that 0 out of 10 analysts rate the stock as a Sell; another 3 rate it as Overweight. Among the rest, 1 recommended ASPN as a Hold, whereas 6 deemed it a Buy, and 0 rated it as Underweight. Aspen Aerogels Inc is expected to report earnings per share of -0.07 for the current quarter.
Aspen Aerogels Inc (NYSE:ASPN) trade information
Instantly ASPN has showed a green trend with a performance of 1.13% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 7.44 on recent trading dayincreased the stock’s daily price by 3.9%. The company’s shares are currently down -39.81% year-to-date, but still up 1.56% over the last five days. On the other hand, Aspen Aerogels Inc (NYSE:ASPN) is -7.98% down in the 30-day period. We can see from the shorts that 8.92 million shares have been sold at a short interest cover period of 4.26 day(s).
The consensus price target as assigned by Wall Street analysts is $33, which translates to bulls needing to increase their stock price by 78.33% from its current value. Analyst projections state that ASPN is forecast to be at a low of $33 and a high of $33.
Aspen Aerogels Inc (ASPN) estimates and forecasts
The year-over-year growth rate is expected to be -13.36%, down from the previous year.
Consensus estimates provided by 7 financial analysts predict the company will bring in an average of 82.75M in revenue for the current quarter. 7 analysts expect Aspen Aerogels Inc to make 90.87M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 94.5M and 117.77M respectively. Analysts predict that the company’s current quarter sales will drop, forecast at -12.44%. Forecasts for the next quarter put sales growth at -22.84%.
Aspen Aerogels Inc earnings are expected to increase by -16.99% in 2025, but the outlook is positive 81.51% per year for the next five years.
ASPN Dividends
Aspen Aerogels Inc’s next quarterly earnings report is expected to be released on 2025-Feb-11.
Aspen Aerogels Inc (NYSE:ASPN)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 16.82% of Aspen Aerogels Inc shares, and 77.93% of them are in the hands of institutional investors. The stock currently has a share float of 93.69%. Aspen Aerogels Inc stock is held by 299.0 institutions, with KIM, LLC being the largest institutional investor. By 2024-06-30, it held 16.0872% of the shares, which is about 12.28 million shares worth $292.89 million.
BLACKROCK INC., with 5.885% or 4.49 million shares worth $107.14 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF were the top two Mutual Funds as of Dec 31, 2024 . The former held 2.57 shares worth $18.4 million, making up 3.13% of all outstanding shares. On the other hand, iShares Russell 2000 ETF held roughly 1.65 shares worth around $11.83 million, which represents about 2.01% of the total shares outstanding.
